Reduced CYR61 expression increases the probability of distant-metastasis free survival (DMFS) of breast cancer patients with a lymph node positive status (Figure 5A; dataset 213226_at; n = 382; FDR 1%; P = 2.8 e−07). Here, CCN1 is linked to breast cancer.